SERPINE1 and neoplasm: Plasminogen activator inhibitor-1 (PAI-1) is a serine protease inhibitor that contributes to tumor-supportive mechanisms such as enhanced angiogenesis and tumor cell survival, thereby leading to unfavorable clinical outcomes in various malignancies, including cutaneous cancers [1,2,3].